Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteria
Authors:
- Sawaek WeerakietSWSawaek Weerakiet
- Pongamon BunnagPBPongamon Bunnag
- Bunyong PhakdeekitcharoenBPBunyong Phakdeekitcharoen
- Surapee WansumrithSWSurapee Wansumrith
- Suwannee ChanprasertyothinSCSuwannee Chanprasertyothin
- Rattiya JultanmasRJRattiya Jultanmas
- Ammarin ThakkinstianATAmmarin Thakkinstian
- 1 January 2007
- journal article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 23 (3) , 153-160
Abstract
Since insulin resistance and compensatory hyperinsulinemia are the major causes of the metabolic syndrome (MS) and are also the main pathophysiology of polycystic ovary syndrome (PCOS), PCOS women are at risk of MS. The aim of the present cross-sectional study was to determine the prevalence of MS in Asian women with PCOS using the International Diabetes Federation (IDF) criteria and to define the risk factors. One hundred and seventy women with PCOS were enrolled in the study from September 3, 2002 to June 14, 2005. A 75-g oral glucose tolerance test with plasma glucose and serum insulin levels was performed. Also, blood samples were examined for fasting triglycerides, high-density lipoprotein cholesterol and adiponectin levels. The mean (+/-standard deviation) age, body mass index (BMI) and waist-to-hip ratio were 28.8+/-5.9 years, 27.1 +/- 7.0 kg/m(2) and 0.85+/-0.06, respectively. The prevalence of MS was 35.3%. Age, BMI, waist circumference and all metabolic parameters were higher in PCOS women with MS than in those without MS. MS prevalence increased with age, BMI and insulin resistance as determined by homeostasis model assessment (HOMA-IR), but not with adiponectin after BMI adjustment. According to the IDF criteria, one-third of the PCOS women had MS. This study also showed that age, BMI and HOMA-IR are important risk factors for MS.Keywords
This publication has 54 references indexed in Scilit:
- Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in BeijingAtherosclerosis, 2006
- Prevalence of the metabolic syndrome among Italian adults according to ATP III definitionNutrition, Metabolism and Cardiovascular Diseases, 2005
- Plasma adiponectin and insulin resistance in women with polycystic ovary syndromeFertility and Sterility, 2005
- Adiponectin Levels in Women With Polycystic Ovary Syndrome and Severe Insulin ResistanceJournal of the Society for Gynecologic Investigation, 2005
- Acanthosis nigricans: Clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndromeGynecological Endocrinology, 2005
- Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in WomenCirculation, 2004
- Adiponectin and Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Screening for Type 2 DiabetesDiabetes Care, 2004
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesJournal of Biological Chemistry, 2003
- Comment on the provisional report from the WHO consultationDiabetic Medicine, 1999